✨ Free AI Report
Sartorius Aktiengesellschaft: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Sartorius Aktiengesellschaft
Company Research

Sartorius Aktiengesellschaft: Business Overview, Financials & Competitive Analysis

Sartorius Aktiengesellschaft scores 7/10 on the AskCyborg Cyborg Score (Strong). Leading-edge bioprocess equipment supplier with strong momentum in cell/gene therapy and margin expansion potential. Sartorius expects 7% revenue growth for 2025, with underlying net profit rising 17%. The company maintains a strong position in an essential market (biopharmaceutical manufacturing), though it faces cyclical demand headwinds. Recent financial improvements and strategic.

What is Sartorius Aktiengesellschaft's industry? Sartorius Aktiengesellschaft (sartorius.com) operates in Biopharmaceutical Equipment & Laboratory Instrumentation. AskCyborg classifies Sartorius Aktiengesellschaft under Biopharmaceutical Equipment & Laboratory Instrumentation in its company registry.

Sartorius AG is an international supplier of pharmaceutical and laboratory equipment, founded in 1870 and headquartered in Göttingen, Germany. The company provides bioprocess solutions and lab products and services wo...

7/ 10Strong

Cyborg Score thesis

Leading-edge bioprocess equipment supplier with strong momentum in cell/gene therapy and margin expansion...

Read the full analyst-debate transcript →
Industry Biopharmaceutical Equipment & Laboratory Instrumentation
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Sartorius Aktiengesellschaft Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Sartorius Aktiengesellschaft

AskCyborg analysts argue the bull and bear cases for Sartorius Aktiengesellschaft across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Sartorius Aktiengesellschaft OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Sartorius Aktiengesellschaft Overview

Pro stress-test →

Sartorius AG is an international supplier of pharmaceutical and laboratory equipment, founded in 1870 and headquartered in Göttingen, Germany. The company provides bioprocess solutions and lab products and services worldwide, serving the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries.

Strategic Profile

Pro stress-test →

The company operates through two divisions: Bioprocess Solutions and Lab Products & Services. Sartorius is rebounding with strong bioprocess segment growth and improving profit margins, despite a challenging biopharma environment. The company has pursued a growth-through-acquisition strategy, integrating multiple biotechnology and laboratory equipment providers to expand its capabilities in critical areas like cell therapy manufacturing and bioanalytical testing.

Competitive Landscape

Pro stress-test →

Key competitors include Merck KGaA, Eppendorf SE, Thermo Fisher Scientific Inc, General Electric Co, and other life sciences equipment providers. Sartorius maintains competitive advantages through its dual-division model, direct expertise in biopharmaceutical manufacturing, and integrated solutions spanning bioprocess and laboratory instruments.

Industry Context

Sartorius Aktiengesellschaft operates in Biopharmaceutical Equipment & Laboratory Instrumentation.

Key facts

Founded: 1870 · Headquarters: Göttingen, Germany · Revenue: $3.38B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Sartorius Aktiengesellschaft.

  • Sartorius marked the first half of 2025 with impressive financial strides, driven by strategic growth in its Bioprocess Solutions Division and a solid profit increase.
  • In 2025, Sartorius partnered with Tulip Interfaces to integrate Tulip's platform with the Sartorius Biobrain automation suite.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2025Sartorius raised FY2025 revenue guidance to 7% growth from 6%, citing strong year-to-date results with 17% underlying net profit increase
  • July 2025Company reported continued growth course for H1 2025 with overproportionate earnings rises
  • +1 moreTrack every material event for Sartorius Aktiengesellschaft as it happens. Explore monitoring →
Get alerted when Sartorius Aktiengesellschaft has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Bioprocess SolutionsBioreactors and cell culture systems→Lab EquipmentLaboratory instruments and consumables→Bioprocess EquipmentCell culture and bioprocess devices→Life Sciences EquipmentLaboratory instruments and supplies→

Compare Sartorius Aktiengesellschaft with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Sartorius Aktiengesellschaft operates in Biopharmaceutical Equipment & Laboratory Instrumentation. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical Equipment & Laboratory Instrumentation research →
NEW · MCP server

Ask your AI assistant about Sartorius Aktiengesellschaft

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Sartorius Aktiengesellschaft and its top competitor on Cyborg Score”
“What did Sartorius Aktiengesellschaft do this quarter?”
“Is Sartorius Aktiengesellschaft a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Sartorius Aktiengesellschaft do?+
Sartorius AG is an international supplier of pharmaceutical and laboratory equipment, founded in 1870 and headquartered in Göttingen, Germany. The company provides bioprocess solutions and lab products and services wo...
What is Sartorius Aktiengesellschaft's Cyborg Score?+
Sartorius Aktiengesellschaft has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Sartorius Aktiengesellschaft's main competitors?+
Named competitors include Bioprocess Solutions, Lab Equipment, Bioprocess Equipment, Life Sciences Equipment. The full competitive landscape is in the AskCyborg report.
How can I get the full Sartorius Aktiengesellschaft research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Sartorius Aktiengesellschaft research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Sartorius Aktiengesellschaft over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.